Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Developmental screening" and "Society guideline links: Rett syndrome".)
International
●The Lancet: Commission on the future of care and clinical research in autism (2021)
●NDD Exome Scoping Review Work Group: Meta-analysis and multidisciplinary consensus statement – Exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders (2019)
●Consensus statement – Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies (2010)
Canada
●Canadian Paediatric Society (CPS): A call for action – Recommendations to improve transition to adult care for youth with complex health care needs (2022)
●CPS: Position statement on early detection for autism spectrum disorder in young children (2019)
●CPS: Position statement on post-diagnostic management and follow-up care for autism spectrum disorder (2019)
●CPS: Position statement on standards of diagnostic assessment for autism spectrum disorder (2019)
●CPS: Position statement on ADHD in children and youth – Part 3: Assessment and treatment with comorbid ASD, ID, or prematurity (2018)
United States
●American Academy of Pediatrics (AAP): Clinical report on pain assessment and treatment in children with significant impairment of the central nervous system (2017, reaffirmed 2022)
●AAP: Clinical report on the evaluation and management of children and adolescents with acute mental health or behavioral problems – Part I: Common clinical challenges of patients with mental health and/or behavioral emergencies (2016, reaffirmed 2022)
●AAP: Clinical report on the evaluation and management of children with acute mental health or behavioral problems – Part II: Recognition of clinically challenging mental health related conditions presenting with medical or uncertain symptoms (2016, reaffirmed 2022)
●American Academy of Neurology (AAN): Practice guideline – Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder (2020)
●AAP: Clinical report on promoting optimal development – Identifying infants and young children with developmental disorders through developmental surveillance and screening (2020)
●AAP: Clinical report on the identification, evaluation, and management of children with autism spectrum disorder (2020)
●American College of Medical Genetics and Genomics (ACMG): Addendum – Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities (2020)
•ACMG: Practice guidelines on array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities (2010)
●Centers for Disease Control and Prevention (CDC): Information on autism spectrum disorder for healthcare providers (reviewed 2020)
●AAP: Clinical report on prescribing physical, occupational, and speech therapy services for children with disabilities (2019)
●AAP: Clinical report on psychosocial factors in children and youth with special health care needs and their families (2019)
●AAP: Clinical report on school-aged children who are not progressing academically – Considerations for pediatricians (2019)
●AAP: Technical report on school readiness (2019)
●AAP: Clinical report on supporting the health care transition from adolescence to adulthood in the medical home (2018)
●ACMG: Clinical practice resource on yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies (2018)
●AAP: Clinical report on shared decision-making and children with disabilities – Pathways to consensus (2017)
●US Preventive Services Task Force (USPSTF): Final recommendation statement – Autism spectrum disorder in young children: Screening (2016)
●ACMG: Clinical genetics evaluation in identifying the etiology of autism spectrum disorders – Guideline revisions (2013)
Europe
●European Society of Child and Adolescent Psychiatry (ESCAP): Practice guidance for autism – A summary of evidence-based recommendations for diagnosis and treatment (2020)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Clinical guideline on autism spectrum disorder in adults – Diagnosis and management (2012, updated 2021)
●NICE: Clinical guideline on autism spectrum disorder in under 19s – Support and management (2013, updated 2021)
●Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus (2020)
●British Association for Psychopharmacology (BAP): Consensus guidelines on assessment, treatment and research on autism spectrum disorder (2018)
●NICE: Clinical guideline on autism spectrum disorder in under 19s – Recognition, referral and diagnosis (2011, updated 2017)
●Scottish Intercollegiate Guidelines Network (SIGN): Assessment, diagnosis and interventions for autism spectrum disorders – A national clinical guideline (2016)
●NICE: Quality standard on autism (2014)
India
●Indian Academy of Pediatrics (IAP): Consensus statement on evaluation and management of autism spectrum disorder (2017)
Australia–New Zealand
●New Zealand Ministry of Health: New Zealand autism spectrum disorder guideline's supplementary paper on the effectiveness of music therapy interventions for children and young people on the autism spectrum (2021)
•New Zealand Ministry of Health: New Zealand autism spectrum disorder guideline's supplementary paper on the effectiveness of physical activity interventions for young people on the autism spectrum (2021)
•New Zealand Ministry of Health: New Zealand autism spectrum disorder guideline supplementary paper on the impact of ethnicity on recognition, diagnosis, education, treatment and support for people on the autism spectrum (2018)
•New Zealand Ministry of Health: New Zealand autism spectrum disorder guideline – Supplementary paper on cognitive behaviour therapy for adults with ASD (2016)
•New Zealand Ministry of Health: New Zealand autism spectrum disorder guideline, 2nd edition (2016)
●Cooperative Research Centre for Living with Autism (Autism CRC): A national guideline for the assessment and diagnosis of autism spectrum disorder in Australia (2018)
